Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
84.18
-1.02 (-1.20%)
At close: Apr 28, 2026, 4:00 PM EDT
83.58
-0.60 (-0.71%)
After-hours: Apr 28, 2026, 6:17 PM EDT
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Rhythm Pharmaceuticals stock have an average target of 131.14, with a low estimate of 94 and a high estimate of 157. The average target predicts an increase of 55.79% from the current stock price of 84.18.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 23, 2026.
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $105 | Strong Buy | Maintains | $100 → $105 | +24.73% | Mar 23, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $131 → $142 | Strong Buy | Maintains | $131 → $142 | +68.69% | Mar 20, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $139 → $149 | Strong Buy | Maintains | $139 → $149 | +77.00% | Mar 20, 2026 |
| Citizens | Citizens | Buy Maintains $152 → $155 | Buy | Maintains | $152 → $155 | +84.13% | Mar 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $110 → $100 | Strong Buy | Maintains | $110 → $100 | +18.79% | Mar 18, 2026 |
Financial Forecast
Revenue This Year
294.77M
from 189.76M
Increased by 55.34%
Revenue Next Year
548.44M
from 294.77M
Increased by 86.06%
EPS This Year
-3.20
from -3.11
EPS Next Year
-0.66
from -3.20
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 330.6M | 653.2M | ||||||
| Avg | 294.8M | 548.4M | ||||||
| Low | 257.7M | 426.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 74.2% | 121.6% | ||||||
| Avg | 55.3% | 86.1% | ||||||
| Low | 35.8% | 44.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.60 | 1.79 | ||||||
| Avg | -3.20 | -0.66 | ||||||
| Low | -3.80 | -1.95 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.